Globally, 5 billion people have access to medication, leaving 2 billion, predominantly in the developing world, who do not. As a challenge that only continues to grow in complexity, with ever-changing regulations and continual development of treatments, market access appears to be the pharmaceutical industry’s mission impossible

Over the past two centuries, the landscape of pharmaceutical marketing has transformed almost beyond recognition. We reflect on the propelling reasons behind such metamorphic change and consider the impact of emerging platforms: from print to radio and from TV to online.

Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future

Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.

Learn about the origins of the medical affairs function, how far it’s come and where it may be heading in the future as key proprietor of patient centricity.

Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Global Medical Affairs, Ipsen shares her thoughts on pharma’s mission to help improve patient lives, challenges that hinder patient centricity and seeking knowledge across industries.

The internet is a jungle, tangled and overgrown, dense with information overload. Among the unkempt chaos lies social media: a treasure trove of possibilities for the pharmaceutical industry.

Establishing a brand-new multinational legal system was never going to be easy, but why has it taken so long and what is the outlook?